Loading clinical trials...
Loading clinical trials...
The purpose of this study is to evaluate the risk of hepatitis B reactivation in patients undergoing allografting.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Azienda Ospedaliera San Giovanni Battista
NCT02269592 · Monoclonal Gammopathy of Undetermined Significance (MGUS), Myelodysplastic Syndromes, and more
NCT07024641 · Hepatitis B Virus Infection
NCT07472972 · Lymphoma, Lymphoid Hematological Malignancies
NCT05856890 · Hepatitis b Virus, Hepatitis B
NCT07333495 · Kidney Transplant, Renal Allograft Recipients, and more
Azienda ospedaliera S Giovanni Battista
Torino
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions